Antimicrobial Agents

Fluoroquinolones Practice Questions

20 free Fluoroquinolones practice questions for the Pharmacology, each with the correct answer and a detailed explanation. Open any question below, or take the full set as an interactive quiz.

Start Practice Quiz

Questions

All Fluoroquinolones questions

20 questions
  1. Q1. Which of the following describes the primary mechanism of action of fluoroquinolones in Gram-negative bacteria?
  2. Q2. Which enzyme is the primary target of fluoroquinolones in Gram-positive organisms such as Streptococcus pneumoniae?
  3. Q3. Fluoroquinolones carry a Boxed Warning from the FDA regarding the increased risk of which musculoskeletal complication?
  4. Q4. Which of the following fluoroquinolones is known as a 'respiratory fluoroquinolone' due to its enhanced activity against S. pneumoniae?
  5. Q5. Which pharmacokinetic interaction significantly reduces the oral bioavailability of fluoroquinolones?
  6. Q6. A patient taking a fluoroquinolone for a complicated UTI is advised to avoid intense sunlight. This is to prevent which adverse effect?
  7. Q7. Which fluoroquinolone is unique because it does not require dose adjustment in renal failure due to its primary elimination via the liver?
  8. Q8. Fluoroquinolones should be used with caution in patients with a history of which cardiac conduction abnormality?
  9. Q9. Which of the following is a CNS-related side effect of fluoroquinolones, particularly in the elderly or those with a history of seizures?
  10. Q10. Ciprofloxacin is a potent inhibitor of which cytochrome P450 enzyme, potentially increasing the levels of Theophylline or Warfarin?
  11. Q11. Which historical 'first-generation' quinolone was used primarily for uncomplicated UTIs but lacked systemic activity?
  12. Q12. Fluoroquinolones are generally avoided in pediatric patients and during pregnancy because of observed toxicity to which tissue in animal studies?
  13. Q13. Which fluoroquinolone has the most potent activity against Pseudomonas aeruginosa?
  14. Q14. A patient on a fluoroquinolone develops sudden onset of severe abdominal or back pain. The clinician must immediately rule out which rare but catastrophic vasc…
  15. Q15. The development of resistance to fluoroquinolones is most commonly due to:
  16. Q16. Which of the following describes the 'post-antibiotic effect' (PAE) of fluoroquinolones?
  17. Q17. Fluoroquinolones can cause significant dysglycemia (both hypo- and hyperglycemia), especially in diabetic patients. Which agent was withdrawn from the market l…
  18. Q18. In the treatment of Anthrax (Bacillus anthracis), which fluoroquinolone is considered a first-line agent for both treatment and post-exposure prophylaxis?
  19. Q19. Which of the following mechanisms contributes to 'plasmid-mediated' quinolone resistance?
  20. Q20. A patient experiences 'brain fog' and peripheral neuropathy after a course of Levofloxacin. These symptoms are part of a syndrome sometimes called: